Search

Search Constraints

You searched for: Author/Creator Clark, Joseph I

Search Results

3. Durability of responses in patients with metastatic renal cell carcinoma treated with high dose interleukin-2 (HD IL-2). (4th November 2015)

4. Efficacy and safety of high-dose interleukin-2 treatment in patients with a history of brain metastases from renal cell carcinoma. (4th November 2015)

7. Long-term progression-free survival of patients with metastatic melanoma or renal cell carcinoma following high-dose interleukin-2. (4th February 2021)

8. Long-term progression-free survival of patients with metastatic melanoma or renal cell carcinoma following high-dose interleukin-2. (4th February 2021)

9. Long-Term Progression-Free Survival of Patients with Metastatic Melanoma or Renal Cell Carcinoma following High-Dose Interleukin-2. (April 2021)

10. Overall survival of metastatic melanoma patients treated with HD IL-2 followed by immune checkpoint blockade of the CTLA-4 or the PD-1 pathways: analysis of data on the current use of HD IL-2. (4th November 2015)